Evolent Health, Inc. (EVH)
CIK 1628908 · all EDGAR filings →
Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.
Shares outstanding over time
Latest: 113.1M shares as of Aug 1, 2026 (10-Q).
Cash runway
Self-funding
generates cash
Full breakdown: cash runway tool · source filing →
Warrants
Warrants outstanding: 1.5M underlying shares, as reported Dec 31, 2020 (10-K).
Rough fully diluted estimate: 114.6M = 113.1M O/S + 1.5M warrant shares. An estimate, not a filing figure: it ignores converts, options and RSUs, and the two inputs carry different as-of dates.
Convertible notes
| Note | Principal | Carrying | Conv. price | Rate | If converted |
|---|---|---|---|---|---|
| Senior Convertible Notes Due 2029 | $402.5M | $395.8M | $38 | 3.5% | ~10.6M sh |
| 3.50 Convertible Senior Notes Due 2029 | $402.5M | — | not tagged | 3.5% | — |
| First Lien Term Loan | $200.0M | $113.4M | not tagged | — | — |
| Second Lien Term Loan | $175.0M | $238.2M | not tagged | — | — |
| Senior Convertible Notes Due 2025 | $172.5M | — | not tagged | 1.5% | — |
| 4.50 Convertible Senior Notes Due 2031 | $166.8M | — | not tagged | 4.5% | — |
| Senior Convertible Notes Due 2031 | $166.8M | $159.5M | $13.53 | 4.5% | ~12.3M sh |
| Credit Facilities | $50.0M | $59.6M | not tagged | — | — |
If every note above converted at its tagged price: ~22.9M new shares on 113.1M currently outstanding. An estimate from principal ÷ conversion price, with inputs carrying different as-of dates; make-whole adjustments, capped calls and partial repurchases are not modeled.
Notes exactly as the company dimensioned them in its 10-Q filed Aug 6, 2026 →. Principal is face amount as tagged, not what remains after repurchases unless the filer updated the tag. A note the filer did not dimension is absent here, not absent from the balance sheet; the exhibits stay the ground truth.
Fully diluted build-up
Shares outstanding plus every potential-share instrument the filer tagged in XBRL, each at its own as-of date. An estimate assembled from filed figures, not a filing figure itself.
| Shares outstanding | 113.1M | Aug 1, 2026 |
| + Warrants (aggregate, as tagged) (if exercised) | 1.5M | Dec 31, 2020 |
| + Senior Convertible Notes Due 2029 (if fully converted) | 10.6M | Jun 30, 2026 |
| + Senior Convertible Notes Due 2031 (if fully converted) | 12.3M | Jun 30, 2026 |
| Fully diluted estimate | 137.5M | +21.6% vs O/S |
Still excluded, because the filer does not tag them in countable form: employee options and RSUs, any instrument living only in exhibit prose, and instruments above missing a share count. Inputs carry different as-of dates, shown per row. Each figure traces to the tranche and note tables above and their cited filings.
Registrations and offerings
Last 12 months: 1 executed · 0 registered.
Full history and shelf status: offering checker · S-3 shelf checker
Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.
Keep going: float checker · offering calendar · short-squeeze screener · full EVH workspace